Trial Profile
Staging of Untreated Patients With Very High-risk and High-risk Prostate Carcinoma Utilizing Hybrid C11-choline PET/MR and Pelvic Multiparametric MRI for Personalized Precise Treatment: a Pilot Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Gadobutrol (Primary)
- Indications Carcinoma; Prostate cancer
- Focus Diagnostic use
- 19 Jan 2021 Status changed from recruiting to completed.
- 23 Jan 2020 Planned End Date changed from 1 Dec 2019 to 1 Sep 2020.
- 23 Jan 2020 Planned primary completion date changed from 1 Dec 2019 to 1 Sep 2020.